Vincent R. Anicetti, Chief Operating Officer at Coherus BioSciences, Inc. (CHRS), sold 2,500 shares at $17.51 ($44K) on 2020-12-17, disclosed to the SEC on 2020-12-21.
Scheduled sale ($44k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CHRS | SELL | 2021-01-21 | $45K | — | Filing → |
| CHRS | SELL | 2020-12-09 | $324K | — | Filing → |
| CHRS | SELL | 2020-12-07 | $3.7M | — | Filing → |